Skip to main content
. Author manuscript; available in PMC: 2015 Jul 21.
Published in final edited form as: J Surg Res. 2011 Jun 25;176(1):121–132. doi: 10.1016/j.jss.2011.05.058

Table 3.

Genes differentially expressed over time (core needle biopsy to surgery) between anastrozole-treated and control groups (p < 0.005).

Target ID Symbol Definition Controls
Log 2
FC		 Anastrozole
treated
Log 2 FC		 Treated
controls
Log 2 FC		 p-value
GI_7549801-S BAG1 Homo sapiens BCL2-
associated athanogene
(BAG1); mRNA.		 −1.85 0.77 2.615 0.0007
GI_4885214-S ERBB4 Homo sapiens v-erb-a
erythroblastic leukemia
viral oncogene homolog 4
(avian) (ERBB4);
mRNA.		 −1.91 0.69 2.597 0.0014
GI_4557879-S IFNGR1 Homo sapiens interferon
gamma receptor 1
(IFNGR1); mRNA.		 −1.49 0.01 1.498 0.0016
GI_4557879-S IFNGR1 Homo sapiens interferon
gamma receptor 1
(IFNGR1); mRNA.		 −1.41 0.11 1.516 0.0043
GI_38201662-A ING1 Homo sapiens inhibitor of
growth family; member 1
(ING1); transcript variant
4; mRNA.		 −1.43 0.74 2.17 0.0010
GI_34147667-S TFDP1 Homo sapiens
transcription factor Dp-1
(TFDP1); mRNA.		 −1.13 0.73 1.858 0.0036

FC: Fold change